Northern Trust Corp Catalyst Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

  • $690 Billion
  • Q4 2024

A detailed history of Northern Trust Corp transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,503,566 shares of CPRX stock, worth $32.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,503,566
Previous 1,383,800 8.65%
Holding current value
$32.5 Million
Previous $27.5 Million 14.07%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$19.73 - $23.93 $2.36 Million - $2.87 Million
119,766 Added 8.65%
1,503,566 $31.4 Million
Q3 2024

Nov 13, 2024
SELL
$15.19 - $21.35 $44,157 - $62,064
-2,907 Reduced 0.21%
1,383,800 $27.5 Million
Q2 2024

Aug 14, 2024
SELL
$14.68 - $16.92 $631,841 - $728,253
-43,041 Reduced 3.01%
1,386,707 $21.5 Million
Q1 2024

May 14, 2024
BUY
$13.18 - $17.11 $145,072 - $188,329
11,007 Added 0.78%
1,429,748 $22.8 Million
Q4 2023

Feb 13, 2024
SELL
$11.78 - $17.29 $217,034 - $318,550
-18,424 Reduced 1.28%
1,418,741 $23.8 Million
Q3 2023

Nov 13, 2023
BUY
$11.69 - $15.02 $353,762 - $454,535
30,262 Added 2.15%
1,437,165 $16.8 Million
Q2 2023

Aug 11, 2023
BUY
$11.5 - $18.08 $163,852 - $257,603
14,248 Added 1.02%
1,406,903 $18.9 Million
Q1 2023

May 15, 2023
SELL
$14.34 - $21.05 $23,790 - $34,921
-1,659 Reduced 0.12%
1,392,655 $23.1 Million
Q4 2022

Feb 13, 2023
BUY
$12.25 - $19.5 $336,299 - $535,333
27,453 Added 2.01%
1,394,314 $25.9 Million
Q3 2022

Nov 14, 2022
BUY
$7.06 - $15.52 $358,146 - $787,314
50,729 Added 3.85%
1,366,861 $17.5 Million
Q2 2022

Aug 12, 2022
SELL
$6.23 - $8.57 $23,431 - $32,231
-3,761 Reduced 0.28%
1,316,132 $9.23 Million
Q1 2022

May 13, 2022
SELL
$5.31 - $8.31 $310,884 - $486,525
-58,547 Reduced 4.25%
1,319,893 $10.9 Million
Q4 2021

Feb 08, 2022
SELL
$5.21 - $7.45 $246,240 - $352,109
-47,263 Reduced 3.32%
1,378,440 $9.33 Million
Q3 2021

Nov 15, 2021
BUY
$4.85 - $6.04 $7,541 - $9,392
1,555 Added 0.11%
1,425,703 $7.56 Million
Q2 2021

Aug 13, 2021
BUY
$4.29 - $6.05 $1.07 Million - $1.51 Million
249,975 Added 21.29%
1,424,148 $8.19 Million
Q1 2021

May 12, 2021
SELL
$3.45 - $4.69 $269,679 - $366,607
-78,168 Reduced 6.24%
1,174,173 $5.41 Million
Q4 2020

Feb 11, 2021
SELL
$2.97 - $3.83 $229,551 - $296,020
-77,290 Reduced 5.81%
1,252,341 $4.18 Million
Q3 2020

Nov 16, 2020
SELL
$2.97 - $5.08 $145,734 - $249,270
-49,069 Reduced 3.56%
1,329,631 $3.95 Million
Q2 2020

Aug 14, 2020
BUY
$3.48 - $5.05 $514,124 - $746,071
147,737 Added 12.0%
1,378,700 $6.37 Million
Q1 2020

May 14, 2020
SELL
$2.61 - $5.21 $12,940 - $25,831
-4,958 Reduced 0.4%
1,230,963 $4.74 Million
Q4 2019

Feb 14, 2020
BUY
$3.67 - $5.7 $165,183 - $256,551
45,009 Added 3.78%
1,235,921 $4.63 Million
Q3 2019

Nov 13, 2019
BUY
$3.89 - $7.43 $129,031 - $246,453
33,170 Added 2.87%
1,190,912 $6.32 Million
Q2 2019

Aug 13, 2019
BUY
$2.7 - $6.11 $82,074 - $185,731
30,398 Added 2.7%
1,157,742 $4.44 Million
Q1 2019

May 13, 2019
SELL
$2.11 - $5.33 $2,736 - $6,913
-1,297 Reduced 0.11%
1,127,344 $5.75 Million
Q4 2018

Feb 12, 2019
SELL
$1.92 - $3.62 $49,338 - $93,023
-25,697 Reduced 2.23%
1,128,641 $2.17 Million
Q3 2018

Nov 14, 2018
BUY
$2.81 - $3.78 $130,367 - $175,369
46,394 Added 4.19%
1,154,338 $4.36 Million
Q2 2018

Sep 18, 2018
SELL
$2.26 - $3.84 $15,044 - $25,562
-6,657 Reduced 0.6%
1,107,944 $3.46 Million
Q2 2018

Aug 14, 2018
BUY
$2.26 - $3.84 $236,518 - $401,871
104,654 Added 10.36%
1,114,601 $3.48 Million
Q1 2018

May 09, 2018
BUY
$2.39 - $4.01 $443,677 - $744,412
185,639 Added 22.52%
1,009,947 $2.41 Million
Q4 2017

Feb 14, 2018
BUY
$2.51 - $4.4 $32,115 - $56,298
12,795 Added 1.58%
824,308 $3.22 Million
Q3 2017

Nov 13, 2017
BUY
$2.4 - $2.94 $1.95 Million - $2.39 Million
811,513
811,513 $2.05 Million

Others Institutions Holding CPRX

# of Institutions
345
Shares Held
98.4M
Call Options Held
13.4K
Put Options Held
11.7K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.22B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email